Skip to main content
Gut logoLink to Gut
. 1985 Jan;26(1):4–7. doi: 10.1136/gut.26.1.4

Infection with the delta agent in children.

P Farci, C Barbera, C Navone, F Bortolotti, P Vajro, N Caporaso, A Vegnente, N Ansaldi, M Rizzetto, P Tolentino, et al.
PMCID: PMC1432404  PMID: 3965366

Abstract

Serological evidence of infection with the hepatitis B virus associated delta agent (delta) was found in 34 of 270 Italian children with HBsAg-positive liver disease. In different histological forms of chronic HBsAg hepatitis the prevalence of delta infection increased in parallel with the activity of the disease and was maximal in children with cirrhosis. During two to seven years of follow up the hepatitis deteriorated in 38% of the 34 patients with delta infection and ameliorated only in 9%. By contrast the disease usually ran a mild course in the 236 delta-negative carriers of HBsAg, with remission in 55% of these children and deterioration in only 7%. The outcome of chronic hepatitis associated with delta infection was not influenced by treatment with steroids and azathioprine. Chronic delta infection in children is usually accompanied by serious liver disease, that has a tendency to progress and is unresponsive to conventional immunosuppressive treatment.

Full text

PDF
4

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bortolotti F., Cadrobbi P., Crivellaro C., Alberti A., Rugge M., Bertaggia A., Realdi G. Changes in hepatitis Be antigen/antibody system in children with chronic hepatitis B virus infection. J Pediatr. 1983 Nov;103(5):718–722. doi: 10.1016/s0022-3476(83)80464-8. [DOI] [PubMed] [Google Scholar]
  2. De Groote J., Desmet V. J., Gedigk P., Korb G., Popper H., Poulsen H., Scheuer P. J., Schmid M., Thaler H., Uehlinger E. A classification of chronic hepatitis. Lancet. 1968 Sep 14;2(7568):626–628. doi: 10.1016/s0140-6736(68)90710-1. [DOI] [PubMed] [Google Scholar]
  3. Govindarajan S., Kanel G. C., Peters R. L. Prevalence of delta-antibody among chronic hepatitis B virus infected patients in the Los Angeles area: its correlation with liver biopsy diagnosis. Gastroenterology. 1983 Jul;85(1):160–162. [PubMed] [Google Scholar]
  4. Hoofnagle J. H. Chronic type B hepatitis. Gastroenterology. 1983 Feb;84(2):422–424. [PubMed] [Google Scholar]
  5. Rizzetto M., Shih J. W., Gocke D. J., Purcell R. H., Verme G., Gerin J. L. Incidence and significance of antibodies to delta antigen in hepatitis B virus infection. Lancet. 1979 Nov 10;2(8150):986–990. doi: 10.1016/s0140-6736(79)92561-3. [DOI] [PubMed] [Google Scholar]
  6. Smedile A., Dentico P., Zanetti A., Sagnelli E., Nordenfelt E., Actis G. C., Rizzetto M. Infection with the delta agent in chronic HBsAg carriers. Gastroenterology. 1981 Dec;81(6):992–997. [PubMed] [Google Scholar]
  7. Smedile A., Lavarini C., Farci P., Aricò S., Marinucci G., Dentico P., Giuliani G., Cargnel A., Del Vecchio Blanco C., Rizzetto M. Epidemiologic patterns of infection with the hepatitis B virus-associated delta agent in Italy. Am J Epidemiol. 1983 Feb;117(2):223–229. doi: 10.1093/oxfordjournals.aje.a113533. [DOI] [PubMed] [Google Scholar]
  8. Weller I. V., Karayiannis P., Lok A. S., Montano L., Bamber M., Thomas H. C., Sherlock S. Significance of delta agent infection in chronic hepatitis B virus infection: a study in British carriers. Gut. 1983 Nov;24(11):1061–1063. doi: 10.1136/gut.24.11.1061. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Zanetti A. R., Ferroni P., Magliano E. M., Pirovano P., Lavarini C., Massaro A. L., Gavinelli R., Fabris C., Rizzetto M. Perinatal transmission of the hepatitis B virus and of the HBV-associated delta agent from mothers to offspring in northern Italy. J Med Virol. 1982;9(2):139–148. doi: 10.1002/jmv.1890090209. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES